Email updates

Keep up to date with the latest news and content from BMC Gastroenterology and BioMed Central.

Download references

Open Access

A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin - Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam)

Federico Coccolini*, Fausto Catena, Luca Ansaloni, Giorgio Ercolani, Salomone Di Saverio, Filippo Gazzotti, Daniel Lazzareschi and Antonio D Pinna

BMC Gastroenterology 2011, 11:42  doi:10.1186/1471-230X-11-42

Include


Format